## Note
nid: 1464300976080
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::!FLAG_THESE_CARDS::!DELETE, #AK_Step1_v11::#B&B::19_Renal::04_Diseases_of_the_Nephron::06_Renal_Failure, #AK_Step1_v11::#FirstAid::08_Endocrine::05_Pharm::06_Cinacalcet, #AK_Step1_v11::#OME::14_Endocrine::04_Parathyroid::02_Unhealthy_Parathyroid_Calcium_Disorders, #AK_Step1_v11::#OME_banner::Basic_Science::03_Genetics, #AK_Step1_v11::#Physeo::09_Pharm::07_Endocrine::11_Cinacalcet, #AK_Step1_v11::#Pixorize::03_Pharm::08_Other_Endocrine::Cinacalcet, #AK_Step1_v11::#SketchyPharm::05_GI_&_Endocrine::03_Thyroid,_Parathyroid_&_Adrenal::03_Teriparatide,_vitamin_D,_cinacalcet,_sevelamer, #AK_Step1_v11::^Other::^HighYield::1-HighYield, #AK_Step1_v11::^Systems::Endocrine::Pharmacology
markdown: false

### Text
<div>
  <b>{{c1::Cinacalcet}}</b> may be used in the treatment of primary
  or secondary <b>{{c2::hyperparathyroidism}}</b> by increasing
  sensitivity to Ca<sup>2+</sup>-sensing receptors
</div>

### Extra
<i>Ca<sup>2+</sup>-sensing receptors are located in the parathyroid
gland <u>and</u> on the kidney; increased sensitivity causes
decreased release of PTH</i>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<div>
  <i>First Aid Pharmacology: Endocrine</i>
</div><img src="paste-83661667958787.jpg">
<div><img src="paste-83889301225475%20(1).jpg"></div>
<div><img src="paste-84520661417987%20(1).jpg"></div>
<div><img src="paste-18567143620611.jpg"><img src=
"paste-18670222835715.jpg"></div>

### Sketchy
<img src="paste-46699179409411.jpg">

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/renal-failure?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_1.png"></a>
</div>

### Additional Resources


### One by one

